HCPLive Network
Latest Oncology Headlines
Friday, December 19, 2014
By Beth Fand Incollingo
Fats in blood and on the body increase men’s prostate cancer risk, two studies have found.
Friday, December 19, 2014
For patients with melanoma arising in head and neck subsites, there is no association between sentinel lymph node biopsy and disease-specific survival, according to research published in the December issue of JAMA Otolaryngology-Head & Neck Surgery.
Friday, December 19, 2014
For patients with bladder cancer, laparoscopic radical cystectomy is associated with good long-term outcomes, according to research published online Dec. 18 in BJU International.
Friday, December 19, 2014
By Andrew J. Roth
The FDA has approved the PARP inhibitor olaparib (Lynparza) for the treatment of women with BRCA-positive advanced ovarian cancer.
Friday, December 19, 2014
By Anita T. Shaffer
Two HER2-targeting regimens anchored by T-DM1 (ado-trastuzumab emtansine; Kadcyla) failed to outperform the standard strategy in women with previously untreated advanced HER2-positive breast cancer in the MARIANNE trial, dealing a blow to efforts to move the drug into frontline settings.
Friday, December 19, 2014
By Andre Goy, MD
Cancers arise from multiple acquired mutations that presumably occur over many years, as shown in a number of models, particularly in colon cancer.
Thursday, December 18, 2014
By Amy Jacob
Scientists in the United Kingdom recently uncovered a new ‘family’ of drugs called padRAF inhibitors that are effective in treating melanoma patients who are resistant to BRAF inhibitors.
Thursday, December 18, 2014
By Amy Jacob
Researchers from the University of Missouri recently published study results indicating testosterone may play an integral role within colon cancer tumor formation.
Thursday, December 18, 2014
Cannabis and cannabinoid pharmaceuticals can be helpful for nausea and vomiting, pain, and weight loss associated with cancer, according to research published online Dec. 10 in CA: A Cancer Journal for Clinicians.
Thursday, December 18, 2014
By Tony Berberabe, MPH
Metastatic melanoma is associated with a poor prognosis, but recent breakthroughs in tumor biology and immune regulation have led to the development of agents that could change clinical practice.
Thursday, December 18, 2014
A new system designed to reduce pathogens in donated blood plasma and reduce the risk of transfusion-transmitted infections has been approved by the US Food and Drug Administration.
Thursday, December 18, 2014
By Marcus Neubauer, MD
Several initiatives that have a dramatic impact on healthcare today were born during that time–managed care, transitioning away from inpatient care toward outpatient care, and the introduction of clinical pathways.
Wednesday, December 17, 2014
By Jacquelyn Gray
For children with Diamond-Blackfan Anemia (DBA) — an inherited condition defined by low red blood cell counts and limited progenitor cells in the bone marrow — growth hormone (GH) therapy was found to increase the short stature of patients — a symptom not widely analyzed.
Wednesday, December 17, 2014
By Komal L. Jhaveri, MD, FACP
When added to standard chemotherapy, trastuzumab not only dramatically improved disease-free survival rates for patients with metastatic disease, but also resulted in a clear survival advantage unprecedented for most treatments of metastatic breast cancer.
Wednesday, December 17, 2014
Digital self-scheduling is set to increase considerably in the next 5 years, according to a report published by Accenture.
Wednesday, December 17, 2014
Staff members who perceive a work climate of crisis mode in their hospital units say that it leads to problems in exchanging patient information, according to research published online Dec. 10 in the Journal of Hospital Medicine.
Wednesday, December 17, 2014
The first national estimates of indoor tanning-related injuries treated in U.S. hospital emergency departments have been calculated, according to the authors of a research letter published online Dec. 15 in JAMA Internal Medicine.
Wednesday, December 17, 2014
By Marcia Frellick
While Laszewski said the Affordable Care Act (ACA), which is driving many of the changes, may end up being altered, he doesn’t expect the program to be disbanded due to the political shift in legislative power.
Tuesday, December 16, 2014
By Silas Inman
The FDA has approved lanreotide for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors.
Monday, December 15, 2014
By Tony Berberabe, MPH
Faced with steep regulations, slashed reimbursement rates, and a shift in focus from fee-for-service (FFS) to delivering value, insurers and physician groups are experimenting with new forms of payment incentives.
Physician's Money Digest
The end of the year has a number of significant financial implications that we should not lose sight of in our merriment. And being aware of some of them will allow us to feel better and maybe save some money, even if we are sometimes profligate in our holiday shopping.
Fredy Revilla, MD, never met a mountain he didn’t like. The neurologist has found a connection between his passion for climbing and his profession of caring for patients with neurological disorders.